Search clinical trials for: trastuzumab (H)

Total 1689 results

Allertein Therapeutics, LLC
Consortium of Food Allergy Research

Completed

Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults

Hypersensitivity | Food Hypersensitivity | Peanut Hypersensitivity | Immediate Hypersensitivity

United States
University of Baghdad

Completed

H - Test Usage in Identification of Sexual Orientation Among People.

Sexual Behavior | Sexual Orientation Conflict Disorder | Sexual Arousal Disorder | Sexual Orientation | Sexual; Orientation, Relationship Disorder

Iraq
University of Zurich

Unknown

Reproducibility of RNFL Circle Scans With ART-Function of Heidelberg Spectralis SD-OCT Software Version 5.3

Glaucoma Patients and Healthy Controls

Switzerland
National Cancer Institute (NCI)

Active, not recruiting

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

Malignant Solid Neoplasm

United States
Zhongmou Therapeutics

Recruiting

Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients

X-linked Retinoschisis

China
Akdeniz University
The Scientific and Technological Research Council of Turkey

Completed

The Effect of an Avatar-Based Education Program on Shunt Complications and Parents' Knowledge and Care Skills

Developing the ABEP-H | Determining the Effect of ABEP-H

Turkey
New York University
Visiting Nurse Service of New York

Withdrawn

The Dementia Symptom Management at Home Program (DSM-H)

Dementia

United States
University Hospital of Cologne

Unknown

24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients (HyperNAFLD)

NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension

Germany
University of Zurich

Unknown

Choroidal Thickness in Glaucoma Patients and Healthy Controls

Glaucoma Patients and Healthy Controls

Switzerland
Peritech Pharma Ltd.

Completed

A Prospective, Randomized, Three Arms, Open Label Study Comparing the Safety and Efficacy of Two Formulations of PP110 to the Active Comparator Preparation-H® Cream in the Treatment of Bleeding Hemorrhoids Grades 2-3

Bleeding Hemorrhoids

Israel
Invizius Limited
Tailored Clinical Research Solutions (TCRS)

Completed

H-Guard Pilot Safety Evaluation in Haemodialysis Patients

Renal Insufficiency | Renal Failure | Renal Disease

United Kingdom
University of Zurich

Terminated

Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCT

Glaucoma Patients and Healthy Controls

Switzerland
University of Zurich

Terminated

Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy Controls

Glaucoma

Switzerland
Seattle Institute for Biomedical and Clinical Research
Eisai Inc.; PriCara, Unit of Ortho-McNeil, Inc.

Completed

The Effect of H. Pylori Infection on Iron Metabolism

Iron Deficiency Anemia | Helicobacter Pylori Infection

United States
Valeritas, Inc.

Terminated

Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device

Type 1 Diabetes | Type 2 Diabetes

United States
University of Erlangen-Nürnberg Medical School

Completed

Immediate Detection of Helicobacter Infection With a New Electrochemical System.

H. Pylori Infection

Germany
Huihua Xiong

Not yet recruiting

A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer

Breast Cancer
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib

Advanced Breast Cancer
Sanofi

Completed

Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer

Breast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Recruiting

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Breast Adenocarcinoma

United States
Hoffmann-La Roche

Terminated

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (LISAH)

Breast Cancer

Austria
National Cancer Institute (NCI)
NRG Oncology

Completed

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7

United States
University of Washington
National Cancer Institute (NCI)

Completed

Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Positive

United States
Hoffmann-La Roche

Completed

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Breast Cancer

Italy
University of Michigan Rogel Cancer Center

Terminated

Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer

Breast Cancer

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers

Metastatic Breast Cancer | Metastatic Gastric Cancer

China
Memorial Sloan Kettering Cancer Center
Novartis

Completed

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Breast Cancer

United States
Xuzhou Medical University

Unknown

Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer

Gastric Cancer

China
The University of Texas Health Science Center at...
National Cancer Institute (NCI)

Withdrawn

Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast Cancer

Breast Cancer
UCB Biopharma SRL

Terminated

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7 | ERBB2 Gene Amplification

United States
Jules Bordet Institute

Completed

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Carcinoma Breast Stage IV

Belgium
Shanghai Zhongshan Hospital

Not yet recruiting

Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer

HER2-positive Gastric Cancer
National University Hospital, Singapore
National University of Singapore

Unknown

NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer

Breast Cancer | Gastric Cancer

Singapore
Anglo Celtic Cooperative Oncology Group

Completed

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Breast Cancer

United Kingdom
Warwick Medical School

Unknown

Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

Breast Cancer

United Kingdom
Comprehensive Support Project for Oncology Research

Completed

National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT] (RESPECT)

Breast Cancer

Japan
Genentech, Inc.

Completed

A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Acura Pharmaceuticals Inc.

Completed

Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users

Opioid-Related Disorders

United States
Medical University of Vienna
Daiichi Sankyo, Inc.

Completed

Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases (TUXEDO-1)

Breast Cancer Stage IV

Austria
Meiji Seika Pharma Co., Ltd.
Dong-A Pharmaceutical

Completed

Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults

Healthy Volunteer

Japan
Armando Santoro, MD

Terminated

Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients

NON-SMALL CELL LUNG CANCER

Italy
Istanbul Physical Medicine Rehabilitation Training...

Completed

Reciprocal Inhibition Versus Reciprocal Facilitation In Spinal Cord Injury Patients

Spinal Cord Injuries

Turkey
Assiut University

Unknown

Helicobacter Pylori Infection in Renal Transplant Patients

Helicobacter Pylori Infection | Renal Transplant Infection
Shalvata Mental Health Center

Unknown

A Randomized Sham-Controlled Study of H-Coil Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Late-Life Depression

Depression

Israel
Amsterdam UMC, location VUmc
AstraZeneca

Recruiting

89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study (HER Image)

Breast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Cancer

Netherlands
Memorial Sloan Kettering Cancer Center

Completed

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Esophagogastric Cancer

United States
National Cancer Institute, France

Completed

Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery

Breast Cancer

France
Zhongmou Therapeutics

Not yet recruiting

Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients (ZM-02)

Retinitis Pigmentosa

China
University Medicine Greifswald

Completed

Side Effects of Mandibular Advancement Devices

Obstructive Sleep Apnea Syndrome | Temporomandibular Disorders

Germany

Search clinical trials for: trastuzumab (H)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations